Cart
sales@molnova.com
Dofetilide
CAS No. 115256-11-6
Dofetilide ( Tikosyn; UK 68789 )
Catalog No. M10538 CAS No. 115256-11-6
Dofetilide is a selective potassium channel ((hERG)) blocker, used as a Class III antiarrhythmic drug
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | In Stock |
|
| 10MG | 57 | In Stock |
|
| 25MG | 107 | In Stock |
|
| 50MG | 168 | In Stock |
|
| 100MG | 237 | In Stock |
|
| 200MG | 455 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDofetilide
-
NoteResearch use only, not for human use.
-
Brief DescriptionDofetilide is a selective potassium channel ((hERG)) blocker, used as a Class III antiarrhythmic drug
-
DescriptionDofetilide is a selective potassium channel ((hERG)) blocker, used as a Class III antiarrhythmic drug.
-
SynonymsTikosyn; UK 68789
-
PathwayCell Cycle/DNA Damage
-
TargetPotassium Channel
-
RecptorPotassium Channel
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number115256-11-6
-
Formula Weight441.56
-
Molecular FormulaC19H27N3O5S2
-
Purity>98%(HPLC)
-
SolubilityDMSO:88 mg/mL warmed (199.29 mM); Ethanol:<1 mg/mL (<1 mM); Water:<1 mg/mL (<1 mM)
-
SMILESCS(=O)(NC1=CC=C(OCCN(CCC2=CC=C(NS(=O)(C)=O)C=C2)C)C=C1)=O
-
Chemical NameN-(4-(2-(methyl(2-(4-(methylsulfonamido)phenoxy)ethyl)amino)ethyl)phenyl)methanesulfonamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kiehn J, et al. Circulation, 1996, 94(10), 2572-2579.
molnova catalog
related products
-
LY2334737
LY2334737 is an orally available prodrug of gemcitabine with antineoplastic activity.
-
PD-118057
A potent, selective hERG potassium channel (Kv11.1) activator that increases peak tail hERG current of 111.1% at 10 uM in HEK293 cells.
-
Margatoxin
Potent KV1.3 channel blocker (IC50 = 36 pM). Displays no effect at calcium-activated channels. Reduces VEGF-induced transmembrane calcium influxes and nitric oxide production in human endothelial cells.
